ReviewBritish journal of cancer2024

Cyclin-dependent kinase 7 (CDK7) inhibitors as a novel therapeutic strategy for different molecular types of breast cancer.

Xue Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.